Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID study

In this cohort of COVID-19 patients, ARDS severity and mortality between severity classes changed substantially over the first 4 days of ventilation. These findings are important, as reclassification could help identify target patients that may benefit from alternative approaches.